-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.USD↓
Mitarbeiter
181
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu COMPASS Pathways plc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu COMPASS Pathways plc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu COMPASS Pathways plc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu COMPASS Pathways plc?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
26 News & Informationen zur COMPASS Pathways plc Aktie
Psychedelics Market Update: H1 2021 in Review
What happened in the psychedelics space in H1 2021? This psychedelics market update covers key trends to watch in this developing space.
COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences
COMPASS Pathways to Participate in BTIG and Canaccord Genuity Investor Conferences…
Tilray's war chest
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.
Ketamine Clinic Company Field Trip Health Debuts On Nasdaq
As the fifth company in the psychedelic space to list on the Nasdaq, Field Trip Health aims to scale its drug-assisted therapy platform across North America with 75 clinics and eventually offer MDMA and psilocybin.
Guy Goodwin Joins COMPASS Pathways As Chief Medical Officer
COMPASS announces changes to its Executive Team
London, UK – 29 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care
Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
COMPASS announces changes to its Executive Team London, UK – 29 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental…
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To “Psychedelics Renaissance”
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday, Field Trip Health Ltd. (TSX:F…
Amazon lobbying on legalization
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.
Psychedelic Therapeutics Startup Cybin To List On NYSE’s Small Cap Market
The Toronto-based startup is currently studying its sublingual formulation of psilocybin, the psychedelic compound found in “magic mushrooms,” to see if it could be a useful treatment for patients with Major Depressive Disorder.
See the 28-page pitch deck that Compass used to convince Founders Fund and Otsuka to bet on psychedelics
We got ahold of the leaked presentation that Compass Pathways used to fuel its rise to one of the world's biggest psychedelics companies.
Is It Too Early to Invest in Psychedelic Stocks?
Legislation is starting to open up the industry but investors who are hoping to cash in on its growth opportunities could be waiting a very long time.
3 Pyschedelic Stocks That Investors Should Keep on Their Radars By StockNews
3 Pyschedelic Stocks That Investors Should Keep on Their Radars
3 Pyschedelic Stocks That Investors Should Keep on Their Radars
ATAI Life Sciences N.V (ATAI), Compass Pathways Plc (CMPS), and Mind Medicine Holdings (MNMD) are 3 stocks that are looking to commercialize psychedel…
10 Best Psychedelic Stocks to Buy Now
In this article, we discuss the 10 best psychedelic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to the 5…
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2021
Upgrades For Royal Dutch Shell PLC (NYSE:RDS), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, Royal …
Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies – ATA (ATAI), Clarmin Explorations (CLXPF), COMP SERVICES (CMPS), Entheon Biomedical (ENTBF),
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps…
10 Psychedelic Startups Investors are Flocking To
In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of these startups, go directly…
COMPASS Pathways joins forces with King's College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
London, UK – 5 July 2021 COMPASS Pathways plc , a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has signed a… | July 5, 2021
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the tr…
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
Institutional analysts are taking a liking to the industry …
3 Top Psychedelic Stocks to Buy Now
These companies developing hallucinogens have more than meets the eye.
COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
London, UK – 30 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating…
Compass Pathways Completes Target Administration Of Psilocybin Therapy In World's Largest Study – COMP SERVICES (CMPS)
Compass Pathways (NASDAQ:CMPS), a biotech company in the p…
COMPASS Pathways Becomes Founding Supporter Of The British Neuroscience Association's Inaugural Scholars Programme
Programme aims to support students from under-represented ethnic groups
London, UK – 23 June 2021
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental
Advances in psychedelics could change investors’ minds
Potential treatments for addiction and mental illnesses are gathering pace
Atai Goes Public With Promising New Mental-Health Treatments Based On Psychedelics
Germany-based Atai Life Sciences (NASDAQ: ATAI), a biotech backed by Peter Thiel, a founder of PayPal, made its public debut Friday. Atai focuses on t…